Tanespimycin: Interim Phase Ib data

By WIR Staff | Dec 18, 2006 | 8:00 AM GMT

Interim data from an ongoing, dose-escalation Phase Ib trial in 23 evaluable patients showed an

Read the full 156 word article

How to gain access

Continue reading with a
two-week free trial.